Recombinant influenza virus vaccines for influenza

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10675345
APP PUB NO 20170368165A1
SERIAL NO

15538133

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are recombinant chimeric influenza virus vaccines and live attenuated influenza virus (LAIV) vaccines expressing foreign (RSV) neutralizing epitopes or conserved M2e epitopes that are capable of providing broader cross-protection against influenza virus and/or protecting against respiratory syncytial virus (RSV) without vaccine-enhanced RSV disease (ERD).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC58 EDGEWOOD AVENUE SE 3RD FLOOR ATLANTA GA 30302

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kang, Sang-Moo Lilburn, US 9 124
Kim, Min-Chul Decatur, US 65 865
Lee, Yu-Na Atlanta, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 9, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 9, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00